Piper Sandler lowers Molson Coors target to $43 and Collegium to $28
Piper Sandler cut its Molson Coors price target to $43 from $44 and kept a Neutral rating, and lowered Collegium's target to $28 from $43.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Piper Sandler lowered its price target on Molson Coors Beverage to $43 from $44 and maintained its Neutral rating, Dow Jones Newswires reported. In a separate note, the same firm cut its target on Collegium Pharmaceutical to $28 from $43.
Both moves are routine analyst actions covering two different companies. The Collegium report does not mention any change to the rating.
why it matters
A single price-target change from one brokerage usually has limited market impact, though it can signal shifting analyst views on a stock.
tags
instruments
sources
- Molson Coors Beverage Price Target Cut to $43.00/Share From $44.00 by Piper Sandler — Dow Jones Newswires, 6 November 2026 at 14:25 UTC
- Collegium Pharmaceutical Price Target Cut to $28.00/Share From $43.00 by Piper Sandler — Dow Jones Newswires, 6 November 2026 at 14:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗